Geovax Labs Stock Price To Earning

GOVXW Stock

USD 0.11 0.01 8.33%

GeoVax Labs fundamentals help investors to digest information that contributes to GeoVax Labs' financial success or failures. It also enables traders to predict the movement of GeoVax Stock. The fundamental analysis module provides a way to measure GeoVax Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GeoVax Labs stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

GeoVax Labs Company Price To Earning Analysis

GeoVax Labs' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

GeoVax Price To Earning Driver Correlations

Understanding the fundamental principles of building solid financial models for GeoVax Labs is extremely important. It helps to project a fair market value of GeoVax Stock properly, considering its historical fundamentals such as Price To Earning. Since GeoVax Labs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GeoVax Labs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GeoVax Labs' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Good Will	Short Term Debt	Current Deferred Revenue	Intangible Assets	Capital Surpluse	Property Plant Equipment	Net Invested Capital	Net Working Capital	Long Term Debt	Short Long Term Debt	Capital Stock
Total Assets		0.97	-0.99	-0.55	0.53	-0.21	0.66	1.0	-0.25	0.08	-0.22	0.1	-0.1	0.72	0.66	0.97	0.97	-0.73	-0.23	-0.72
Total Stockholder Equity	0.97		-0.96	-0.45	0.41	-0.14	0.47	0.97	-0.25	0.03	-0.14	0.05	-0.06	0.62	0.6	0.97	0.97	-0.62	-0.14	-0.63
Net Debt	-0.99	-0.96		0.57	-0.55	0.19	-0.68	-0.99	0.27	-0.17	0.22	-0.16	0.2	-0.72	-0.69	-0.98	-0.98	0.75	0.27	0.76
Retained Earnings	-0.55	-0.45	0.57		-0.95	0.42	-0.64	-0.52	0.23	-0.48	0.42	-0.32	0.35	-0.8	-0.82	-0.62	-0.59	0.81	0.56	0.86
Accounts Payable	0.53	0.41	-0.55	-0.95		-0.41	0.7	0.51	-0.35	0.35	-0.36	0.17	-0.19	0.76	0.86	0.57	0.54	-0.77	-0.46	-0.85
Net Receivables	-0.21	-0.14	0.19	0.42	-0.41		-0.35	-0.2	-0.01	0.25	0.37	0.33	-0.25	-0.22	-0.21	-0.18	-0.18	0.24	0.27	0.24
Total Liab	0.66	0.47	-0.68	-0.64	0.7	-0.35		0.66	-0.17	0.22	-0.38	0.22	-0.22	0.74	0.58	0.57	0.58	-0.75	-0.43	-0.72
Total Current Assets	1.0	0.97	-0.99	-0.52	0.51	-0.2	0.66		-0.25	0.07	-0.22	0.09	-0.1	0.72	0.65	0.97	0.97	-0.72	-0.23	-0.72
Common Stock	-0.25	-0.25	0.27	0.23	-0.35	-0.01	-0.17	-0.25		-0.04	0.42	0.02	-0.06	-0.34	-0.51	-0.25	-0.25	0.44	0.42	0.41
Good Will	0.08	0.03	-0.17	-0.48	0.35	0.25	0.22	0.07	-0.04		0.06	0.93	-0.95	0.3	0.3	0.19	0.17	-0.32	-0.28	-0.34
Short Term Debt	-0.22	-0.14	0.22	0.42	-0.36	0.37	-0.38	-0.22	0.42	0.06		0.14	-0.1	-0.41	-0.24	-0.23	-0.22	0.57	0.94	0.42
Current Deferred Revenue	0.1	0.05	-0.16	-0.32	0.17	0.33	0.22	0.09	0.02	0.93	0.14		-0.95	0.3	0.15	0.15	0.12	-0.26	-0.16	-0.22
Intangible Assets	-0.1	-0.06	0.2	0.35	-0.19	-0.25	-0.22	-0.1	-0.06	-0.95	-0.1	-0.95		-0.25	-0.17	-0.18	-0.17	0.27	0.23	0.25
Capital Surpluse	0.72	0.62	-0.72	-0.8	0.76	-0.22	0.74	0.72	-0.34	0.3	-0.41	0.3	-0.25		0.84	0.73	0.7	-0.96	-0.47	-0.93
Property Plant Equipment	0.66	0.6	-0.69	-0.82	0.86	-0.21	0.58	0.65	-0.51	0.3	-0.24	0.15	-0.17	0.84		0.72	0.7	-0.85	-0.33	-0.95
Net Invested Capital	0.97	0.97	-0.98	-0.62	0.57	-0.18	0.57	0.97	-0.25	0.19	-0.23	0.15	-0.18	0.73	0.72		1.0	-0.76	-0.28	-0.78
Net Working Capital	0.97	0.97	-0.98	-0.59	0.54	-0.18	0.58	0.97	-0.25	0.17	-0.22	0.12	-0.17	0.7	0.7	1.0		-0.74	-0.27	-0.76
Long Term Debt	-0.73	-0.62	0.75	0.81	-0.77	0.24	-0.75	-0.72	0.44	-0.32	0.57	-0.26	0.27	-0.96	-0.85	-0.76	-0.74		0.64	0.96
Short Long Term Debt	-0.23	-0.14	0.27	0.56	-0.46	0.27	-0.43	-0.23	0.42	-0.28	0.94	-0.16	0.23	-0.47	-0.33	-0.28	-0.27	0.64		0.51
Capital Stock	-0.72	-0.63	0.76	0.86	-0.85	0.24	-0.72	-0.72	0.41	-0.34	0.42	-0.22	0.25	-0.93	-0.95	-0.78	-0.76	0.96	0.51

Click cells to compare fundamentals

Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Competition

Predict GeoVax Labs

GeoVax Retained Earnings

Retained Earnings

(99.15 Million)

GeoVax Labs reported Retained Earnings of (104.36 Million) in 2023

Based on the latest financial disclosure, GeoVax Labs has a Price To Earning of 0.0 times. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Earnings Calls Now

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges

All Next

Launch Module

GeoVax Fundamentals

	Return On Equity	-3.62
	Return On Asset	-1.34
	Operating Margin	(16.84) %
	Number Of Shares Shorted	330
	EBITDA	(26.67 M)
	Net Income	(25.97 M)
	Cash And Equivalents	710.68 K
	Cash Per Share	0.92 X
	Total Debt	3.52 M
	Current Ratio	0.34 X
	Book Value Per Share	2.92 X
	Cash Flow From Operations	(25.17 M)
	Number Of Employees	17
	Beta	3.11
	Total Asset	9.28 M
	Retained Earnings	(104.36 M)
	Working Capital	4.37 M
	Net Asset	9.28 M

About GeoVax Labs Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze GeoVax Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeoVax Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeoVax Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC